Skip to main content

WellSpan Health and Cancer Care Associates of York mark first day of integrated cancer care partnership

WellSpan Health and Cancer Care Associates of York mark first day of integrated cancer care partnership

Two trusted organizations unite to deliver connected, patient-centered cancer care through one seamless program.
Two trusted organizations unite to deliver connected, patient-centered cancer care through one seamless program.

York, PA, July 06, 2026 (GLOBE NEWSWIRE) — WellSpan Health and Cancer Care Associates of York (CCAY) today marked the official start of their integrated operating arrangement, bringing together two trusted organizations to deliver a more connected, patient-centered cancer care experience across York County and the broader region.

The arrangement brings CCAY’s medical oncology team into the WellSpan Cancer Institute, strengthening a coordinated approach that integrates medical oncology, infusion, radiation oncology, research and support services into one seamless program.

“This is an important milestone for our patients and our community,” said Roxanna Gapstur, Ph.D., R.N., president and CEO, WellSpan Health. “Together, we are building on a shared commitment to provide high-quality cancer care that is easier to navigate and designed around the needs of each individual we serve. By bringing our teams together, we are advancing a more connected system of care that supports better outcomes and a better experience for every patient.”

As of today, CCAY’s clinical operations are integrated into WellSpan’s oncology program, allowing expanded access to coordinated services, clinical trials and advanced cancer treatments. The arrangement also enables a unified electronic health record, creating a single, comprehensive view of each patient’s care and improving communication across the care team.

“This arrangement reflects a shared vision to elevate cancer care in our community,” said Dr. Kevin L. Lewis, executive vice president and chief physician executive, WellSpan Health. “Together we are strengthening our ability to deliver the right care, at the right time, in the right place, all while maintaining the relationships that matter most to our patients.”

“Today marks an important step forward for our patients and our team,” said Dr. Daniel Efiom Ekaha, oncologist and president, Cancer Care Associates of York. “Joining WellSpan allows us to expand access to advanced treatments, research and coordinated services, while continuing to serve our community with the same focus and dedication our patients know and trust.”

Today’s milestone builds on months of planning and collaboration focused on ensuring a smooth transition for patients and team members. CCAY physicians and advanced practice professionals will continue delivering care within WellSpan-operated clinical settings, working alongside WellSpan care teams as part of one integrated oncology program.

Patients will continue to receive care from the same experienced oncology team, now supported by the expanded capabilities of the WellSpan Cancer Institute — a regional network that offers advanced services such as precision medicine, robotic-assisted surgery and access to hundreds of clinical trials.

To learn more about WellSpan’s Cancer Institute, visit www.WellSpan.org/Cancer

Attachment

CONTACT: Ryan Coyle
WellSpan Health
7178513151
RCoyle@WellSpan.org

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.